Dissociation of Human Chorionic Gonadotrophin into its Free Subunits is Dependent on Naturally Occurring Molecular Structural Variation, Sample Matrix and Storage Conditions

Measurement of human chorionic gonadotrophin (hCG) is used in many areas of clinical medicine. Recent interest has focused on the stability of this molecule and its fragments during sample storage. In the body hCG is degraded and removed by specific metabolic processes which begin while the molecule is in the bloodstream. In particular, the receptor binding loop of the β subunit is cut or ‘nicked’, initiating a catabolic cascade. Furthermore, the extent and nature of glycosylation is believed to have a significant influence on this process. In these studies we incubated seven glycoforms of hCG, each with different degrees of ‘nicking’, in phosphate-buffered saline, serum, defibrinated blood and urine from healthy non-pregnant women, under varying conditions. Degradation was expressed as the molar increase in free β subunit. Under all conditions there was a steady dissociation of hCG over time, the process being more rapid at higher temperatures. ‘Nicked’ hCG dissociated more rapidly than did non-‘nicked’ hCG. Glycosylation reduced the rate of dissociation. Dissociation was most rapid in urine and buffer solutions, and slowest in serum and defibrinated blood.

[1]  K. Wenstrom,et al.  Free β‐hCG Subunit Versus Intact hCG in Down Syndrome Screening , 1997 .

[2]  L. Cole,et al.  THE STABILITY OF hCG AND FREE β‐SUBUNIT IN SERUM SAMPLES , 1997 .

[3]  R. Iles Urinary analysis for Down's syndrome: is the measurement of urinary beta-core the future of biochemical screening for Down's syndrome. , 1996, Early human development.

[4]  D. Goldie,et al.  Down's Syndrome Screening Using Free βhCG: Instability Can Significantly Increase the Down's Risk Estimate , 1996, Annals of clinical biochemistry.

[5]  K. Spencer,et al.  URINE FREE BETA hCG AND BETA CORE IN PREGNANCIES AFFECTED BY DOWN'S SYNDROME , 1996, Prenatal diagnosis.

[6]  H. Cuckle,et al.  Posting maternal blood samples for free β‐human chorionic gonadotrophin testing , 1995 .

[7]  H. Cuckle,et al.  Urinary multiple marker screening for down's syndrome , 1995, Prenatal diagnosis.

[8]  D. Bahner,et al.  The effect of thermal instability of intact human chorionic gonadotropin (ihcg) on the application of its free β‐subunit (free βhcg) as a serum marker in down syndrome screening , 1995, Prenatal diagnosis.

[9]  N. R. Thotakura,et al.  Glycoprotein hormones: glycobiology of gonadotrophins, thyrotrophin and free alpha subunit. , 1995, Glycobiology.

[10]  R. Henley,et al.  The stability of blood samples for the measurement of the free β subunit of chorionic gonadotrophin , 1995, Prenatal diagnosis.

[11]  H. Cuckle,et al.  Posting maternal blood samples for free beta-human chorionic gonadotrophin testing. , 1995, Prenatal Diagnosis.

[12]  L. Cole,et al.  Human chorionic gonadotropin beta-subunit nicking enzymes in pregnancy and cancer patient serum. , 1994, The Journal of clinical endocrinology and metabolism.

[13]  W A Hendrickson,et al.  Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein. , 1994, Structure.

[14]  H. Cuckle,et al.  Maternal serum-free beta-human chorionic gonadotrophin level: the effect of sample transportation. , 1994, Annals of Clinical Biochemistry.

[15]  T. Chard,et al.  Molecular insights into the structure and function of human chorionic gonadotrophin. , 1993, Journal of molecular endocrinology.

[16]  K. Spencer,et al.  Stability of intact chorionic gonadotropin (hCG) in serum, liquid whole blood, and dried whole-blood filter-paper spots: impact on screening for Down syndrome by measurement of free beta-hCG subunit. , 1993, Clinical chemistry.

[17]  L. Cole,et al.  The deactivation of hCG by nicking and dissociation. , 1993, The Journal of clinical endocrinology and metabolism.

[18]  B. Sheridan,et al.  Serum Free β-Human Chorionic Gonadotrophin Concentrations Increase in Unseparated Blood Specimens , 1993, Annals of clinical biochemistry.

[19]  R. Norman,et al.  Stability of immunoreactive beta-core fragment of hCG. , 1991, Obstetrics and gynecology.

[20]  U. Stenman,et al.  Choriogonadotropin and its beta subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. , 1988, Clinical chemistry.

[21]  D. Blithe,et al.  Purification of β-Core Fragment from Pregnancy Urine and Demonstration That Its Carbohydrate Moieties Differ from Those of Native Human Chorionic Gonadotropin-β , 1988 .

[22]  O. P. Bahl,et al.  Characterization of glycoproteins: carbohydrate structures of glycoprotein hormones. , 1986, Advances in experimental medicine and biology.

[23]  T. Chard,et al.  Increase of HCG levels following heating of serum , 1984 .

[24]  O. P. Bahl,et al.  Human chorionic gonadotropin: amino acid sequence of the alpha and beta subunits. , 1972, Biochemical and biophysical research communications.

[25]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.